CHAMPIONS ONCOLOGY, INC. (CSBR) › Shareholders' EquityCHAMPIONS ONCOLOGY, INC. (CSBR) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2010: $1.58M2011: $19.0K2012: -$5.28M2013: -$9.21M2014: $3.20M2015: $8.06M2016: $238.0K2017: $400.0K2018: $3.0K2019: $2.14M2020: $5.10M2021: $7.43M2022: $9.10M2023: $4.64M2024: -$1.90M2025: $3.77M$3.77M2010Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$3.77M+298.2%2024-$1.90M-141.0%2023$4.64M-49.0%2022$9.10M+22.5%2021$7.43M+45.7%2020$5.10M+138.6%2019$2.14M+71133.3%2018$3.0K-99.2%2017$400.0K+68.1%2016$238.0K-97.0%2015$8.06M+152.1%2014$3.20M+134.7%2013-$9.21M-74.4%2012-$5.28M-27878.9%2011$19.0K-98.8%2010$1.58M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share